Author

Lauren McCormick

National Institutes of HealthORCID 0000-0003-4928-3008Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Research Focus:benchmarking· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

Daniel C. DouekiD· 3 shared Amy R. Henry· 2 shared Christopher Cole HoneycuttiD· 2 shared Sucheta GodboleiD· 2 shared Adi Naamti· 1 shared Adriano Leuzzi· 1 shared Adrianus C. M. BooniD· 1 shared Ahmet Can BerkyurekiD· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Daniel C. DouekORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 16, 2026

Stability of Antibody Repertoires in Astronauts During Long-Term Spaceflight

Rohit Farmer, Yoav Pinto, Sucheta Godbole…·Daniel C. Douek

This study shows that antiviral antibody levels remain stable in astronauts during and after long-term spaceflight, despite potential changes in cellular immunity.

DOI 10.64898/2026.09.11.750652

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintNov 22, 2023

Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates

Juan I. Moliva, Shayne F. Andrew, Barbara J. Flynn…·Nancy J. Sullivan

This study shows a gorilla adenovirus-based vaccine provides durable immunity against SARS-CoV-2 in both airways of non-human primates, with enhanced protection from aerosol delivery and prime-boost regimens.

DOI 10.1101/2023.11.22.567930

non-human primateproteomics

𝕏 PostBluesky

GenomicsbioRxivPreprintApr 12, 2022

Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxis

Ohad Yogev, Omer Weissbrod, Giorgia Battistoni…·Yaniv Erlich

The paper identifies potent siRNAs against SARS-CoV-2 through RNAi screening, validates their efficacy against variants, and demonstrates their prophylactic potential in a hamster model.

5 citations

mouseexperimental assay

𝕏 PostBluesky